JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosisSaida Abdelli(University Hospital of Lausanne), Christophe Bonny(University Hospital of Lausanne)DiabetologiaJuly 15, 200910.1007/s00125-009-1431-7Cited by 47SaveCiteExport RISWatch citationsRelated PapersCell-Permeable Peptide Inhibitors of JNK|Diabetes|2001|570JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling|PLoS ONE|2012|28